Skip to main content

Table 5 Prescribed acute and emergency medications for patients with migraine in the German Company Sickness Fund Database 2016

From: Administrative prevalence and incidence, characteristics and prescription patterns of patients with migraine in Germany: a retrospective claims data analysis

Acute medication Percentage of all prescriptions for acute medications
Anti-emeticsa 4.5%
 Metoclopramide 3.7%
Analgesics/non-steroidal anti-inflammatory drugsb 74.2%
 Ibuprofen 23.7%
 Metamizole 19.7%
 Opioids 19.1%
 Diclofenac 7.9%
 Cyclooxygenase-2 inhibitors (‘coxibs’) 2.5%
 Naproxen 1.1%
Selective serotonin (5-HT1) agonists (triptans)c 21.2%
 Sumatriptand (all administration routes) 12.3%
 Rizatriptan 4.7%
 Zolmitriptane (all administration routes) 2.6%
Emergency medicationf Percentage of all prescriptions for emergency medications
Dexamethasone 51.3%
Prednisone 25.4%
Sumatriptan (subcutaneous) 13.9%
Metamizole (intravenous) 7.9%
Acetylsalicylic acid (intravenous) 1.2%
  1. Subcutaneous sumatriptan is considered both an acute and emergency medication according to the German guideline for migraine so all identified subcutaneous sumatriptan prescriptions were included as both acute and emergency medications
  2. aAlso includes dimenhydrinate (0.10% of acute prescriptions) and domperidone (0.66%)
  3. bAlso includes acetylsalicylic acid (0.04% of acute prescriptions), paracetamol (0.10%), ergotamine (0.05%), ketoprofen (0.03%), dexketoprofen (0.20%) and other analgesics (0.92%)
  4. cAlso includes eleptriptan (0.18% of acute prescriptions), almotriptan (0.06%), naratriptan (0.99%) and frovatriptan (0.38%)
  5. dIncludes sumatriptan oral (11.8% of acute prescriptions), nasal (0.20%), rectal (0.07%) and subcutaneous (0.27%)
  6. eIncludes zolmitriptan oral (1.6% of acute prescriptions) and nasal (1.0%)
  7. fAlso includes metoclopramide (intravenous: 0.33% of emergency prescriptions)
\